Fahr's disease is a hereditary genetic condition marked by abnormal calcium deposits in parts of the brain that regulate movement. Basal ganglia, cerebral, and cortical regions (parts of the brain) have calcium deposits that cause atrophy. Motor and mental problems result from the considerable neuron (brain cell) loss caused by this mineral deposit.
There is a paucity of molecular and genetic evidence about the molecular genetics of Fahr's disease. However, one of the genes responsible for idiopathic basal ganglia calcification has been identified as IBGC1. Chromosomes 8 and 2 are found to be a second locus for the genetic pathogenesis of Fahr's disease. Fahr's disease typically affects people in their 40s and 50s, though it can also strike children or teenagers. The prevalence of the disease is lower than 1 in 1,000,000.
There is no cure available for this disease. Treatments are, however, available.
Fahr syndrome treatment
1. Fahr disease has no known specific treatments as of yet.
2. Treatment options for this condition's symptoms, including movement problems, seizures, anxiety, depression, psychosis, and urine incontinence, include medications.
3. Few people have reported receiving bisphosphonates outside of their prescribed dosage.
4. Each patient's symptoms are addressed specifically through treatment.
5. Any person with Fahr's disease has an unpredictable and difficult-to-predict prognosis.
Deterioration of motor function,Dementia,Seizures,Headache
Spasticity,Gait disorder,Speech impairment,Dementia,Parkinsonism,Chorea,Tremors,Dystonia,Myoclonus,Coma